Mares J - Search Results

1

The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome.

Babjuk M, Soukup V, Mares J, Dusková J, Sedlácek Z, Trková M, Pecen L, Dvorácek J, Hanus T, Kocvara R, Novák J, Povýsil C. Babjuk M, et al. Among authors: mares j. Int Urol Nephrol. 2002;34(4):495-501. doi: 10.1023/a:1025652203472. Int Urol Nephrol. 2002. PMID: 14577491

2

Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.

Trkova M, Babjuk M, Duskova J, Benesova-Minarikova L, Soukup V, Mares J, Minarik M, Sedlacek Z. Trkova M, et al. Among authors: mares j. Cancer Lett. 2006 Oct 8;242(1):68-76. doi: 10.1016/j.canlet.2005.10.036. Epub 2005 Dec 15. Cancer Lett. 2006. PMID: 16343743

3

Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder.

Babjuk M, Soukup V, Mares J, Dusková J, Pecen L, Pesl M, Pavlík I, DvorRcek J. Babjuk M, et al. Among authors: mares j. Urology. 2006 Apr;67(4):756-61. doi: 10.1016/j.urology.2005.10.053. Epub 2006 Mar 29. Urology. 2006. PMID: 16566978

4

Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.

Mares J, Szakacsova M, Soukup V, Duskova J, Horinek A, Babjuk M. Mares J, et al. Neoplasma. 2013;60(3):295-301. doi: 10.4149/neo_2013_0391. Neoplasma. 2013. PMID: 23452234

5

Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.

Brisuda A, Pazourkova E, Soukup V, Horinek A, Hrbáček J, Capoun O, Svobodova I, Pospisilova S, Korabecna M, Mares J, Hanuš T, Babjuk M. Brisuda A, et al. Among authors: mares j. Urol Int. 2016;96(1):25-31. doi: 10.1159/000438828. Epub 2015 Sep 3. Urol Int. 2016. PMID: 26338254

6

[Expression of PAX2 and PAX8 genes in conventional type of renal carcinoma and their role in the tumor prognosis].

Viktorová T, Babjuk M, Dusková J, Stolz J, Goetz P, Mares J. Viktorová T, et al. Among authors: mares j. Cas Lek Cesk. 2005;144 Suppl 2:30-3. Cas Lek Cesk. 2005. PMID: 16277182 Czech.

7

Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs.

Pazourkova E, Pospisilova S, Svobodova I, Horinek A, Brisuda A, Soukup V, Hrbacek J, Capoun O, Mares J, Hanus T, Babjuk M, Korabecna M. Pazourkova E, et al. Among authors: mares j. Adv Exp Med Biol. 2016;924:97-100. doi: 10.1007/978-3-319-42044-8_18. Adv Exp Med Biol. 2016. PMID: 27753026

8

[Tumor suppressor genes].

Sedlácek Z, Mares J, Goetz P. Sedlácek Z, et al. Among authors: mares j. Cas Lek Cesk. 1997 Jan 8;136(1):11-6. Cas Lek Cesk. 1997. PMID: 9147846 Czech.

9

Gene expression analysis for the prediction of recurrence in patients with primary Ta urothelial cell carcinoma.

Schultz IJ, Wester K, Straatman H, Kiemeney LA, Babjuk M, Mares J, Willems JL, Swinkels DW, Witjes JA, Malmström PU, de Kok JB. Schultz IJ, et al. Among authors: mares j. Eur Urol. 2007 Feb;51(2):416-22; discussion 422-3. doi: 10.1016/j.eururo.2006.07.023. Epub 2006 Aug 7. Eur Urol. 2007. PMID: 16920253

10

[Oncogenes and the malignancy process].

Mares J, Sedlácek Z, Goetz P. Mares J, et al. Cas Lek Cesk. 1996 May 29;135(11):335-9. Cas Lek Cesk. 1996. PMID: 8706068 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

617 results

Search Page

Filters